Story
UnitedHealth Shows Stronger Fundamentals Than Humana on Valuation and Profitability Metrics
Summary
Despite trading at similar price points, an analysis shows UnitedHealth Group holds a clear advantage over Humana in key areas including forward valuation, return on equity, and recent earnings momentum.
Health insurance giants UnitedHealth Group (UNH) and Humana (HUM) are trading at nearly identical stock prices, but an analysis of their financial data reveals a stark divergence in fundamental strength and investor sentiment. According to data from September 22, 2026, UnitedHealth demonstrates superior profitability, a more attractive valuation, and stronger earnings momentum compared to Humana.
Valuation and Profitability Diverge
While both companies have seen revenue growth, their profitability and valuation metrics tell different stories. UnitedHealth, with a market capitalization of $338.90 billion, is substantially larger than Humana at $45.46 billion.
More critically, UnitedHealth appears more attractively valued and profitable. The company's return on equity (ROE) stands at 14.6%, more than double Humana's 6.8%. On a forward-looking basis, UnitedHealth trades at a price-to-earnings (P/E) ratio of 18.9x, significantly lower than Humana's 42.3x, suggesting a more favorable valuation relative to expected earnings.
A Clear Split in Earnings Momentum
The most recent earnings cycle highlights a significant gap in performance and subsequent market reaction. UnitedHealth's results and analyst revisions point to a much stronger operational footing.
Ad- Q2 2026 Earnings: UnitedHealth beat earnings per share (EPS) estimates by a substantial 31.55%, while Humana delivered a narrower 5.26% beat.
- Stock Reaction: Following the results, UNH stock saw a positive 1.81% price reaction, whereas HUM stock fell 5.67%.
- Analyst Revisions: Over the past 90 days, consensus EPS estimates for UnitedHealth have risen 11.20%. In sharp contrast, estimates for Humana have been revised downward by a dramatic 490.75%.
Market Performance vs. Fundamentals
Despite its weaker fundamentals, Humana's stock has staged a powerful recovery, gaining 118.89% over the last six months, far outpacing UnitedHealth's 35.68% rise. This rally suggests investors have already priced in significant optimism for a turnaround at Humana.
For investors, the data presents a choice between two distinct profiles. UnitedHealth offers a stronger position based on current quality, profitability, and valuation metrics. Humana, on the other hand, represents a higher-risk recovery play, with its recent stock performance running well ahead of its challenged earnings picture.
Read next
More on Stocks
Sixth Street Renews Bid for Brighthouse Financial Amid Scrutiny of Existing Deal, Bloomberg Reports
Sixth Street has reportedly revived its offer to acquire insurer Brighthouse Financial, as the company's current sale agreement with Aquarian Holdings faces a regulatory review over its funding.
Microsoft Grants DARPA On-Site Access to Quantum Computer for Evaluation
The U.S. Defense Advanced Research Projects Agency will gain direct, hands-on access to Microsoft's latest quantum hardware at a new Maryland facility, a key step in evaluating the technology's national security applications and economic viability.
Brightline Prepares for Chapter 11 Filing to Restructure Corporate Debt, Bloomberg Reports
Florida's private passenger railroad Brightline is reportedly preparing a Chapter 11 bankruptcy filing to restructure approximately $1.1 billion in corporate debt, according to a Bloomberg report. The move is not expected to impact train operations.
Microsoft Agrees to Maintain Shareholder Proposal Thresholds for One Year Amid SEC Review
Microsoft has entered a one-year agreement with an activist investor to uphold current eligibility rules for shareholder proposals, providing clarity as the SEC considers changes that critics say could curb investor rights.